Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Hepion Pharmaceuticals, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Gary Stetz, Chief Financial Officer (Form 8-K filed 2026-10-09). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Ki Holdings LTD. (filed 2026-09-16).
Who is behind it
Hepion Pharmaceuticals, Inc.: incorporated in Delaware; business address in Red Bank, New Jersey; industry Pharmaceutical Preparations (Form D, 2026-10-09).
Officers and directors, each with the role and the filing that names them:
- Gary Stetz: Executive Officer, Director (Form D, 2026-08-05)
- Vincent LoPriore: Executive Officer, Director (Form D, 2026-08-05)
- Sireesh Appajosyula: Director (Form D, 2026-08-05)
- Chase LoPriore: Director (Form D, 2026-08-05)
- Michael Purcell: Director (Form D, 2026-08-05)
- Dania Fisher: Director (Form D, 2026-08-05)
- Gary S. Stetz, II: Director (Form D, 2026-08-05)
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-09-16 | Ki Holdings LTD. | 10.2% |
| Schedule 13G, 2026-09-15 | Kenneth Rickel | 5.7% |
| Schedule 13D, 2026-08-20 | Sireesh Appajosyula | 5.7% |
| Schedule 13D, 2026-08-20 | Gary Stetz | 5.7% |
| Schedule 13D/A, 2026-08-20 | Vincent Lopriore | 26.2% |
| Schedule 13D, 2026-08-07 | Black Global 5 LLC | 11.1% |
| Schedule 13D, 2026-05-01 | Vincent Lopriore | 21.46% |
| Schedule 13G/A, 2025-08-14 | S.H.N. Financial Investments LTD. | 0% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-10-09 | Gary Stetz | Chief Financial Officer | appointed | 2026-10-09 |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2026-08-05 | $3.06M | $3.06M |
| Form D, 2026-04-22 | $700K | $700K |
| Form D, 2024-07-24 | $2.90M | $2.90M |
| Form D, 2023-10-03 | $5M | $5M |
| Form D, 2022-11-15 | $20M | $20M |
Latest IPO step: Hepion Pharmaceuticals, Inc. filed its final IPO prospectus, ticker HEPA (424B4, 2025-01-23).
IPO filings: 424B4, 2025-01-23, S-1/A, 2025-01-14, S-1, 2024-12-26, S-1, 2024-07-11; ticker HEPA on Nasdaq Capital Market.
Acquisitions reported on Form 8-K, Item 2.01: acquired Gravitas Life Sciences, LLC (2026-10-09).
Related pages
Funding and filing history5%+ holdersCourt record
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/hepion-pharmaceuticals-inc